Regeneron Pharmaceuticals | REGN - Ebitda

Stock Price
745.57
Daily Change
-9.46 -1.25%
Monthly
-2.31%
Yearly
11.80%
Q1 Forecast
718.61

Regeneron Pharmaceuticals reported $1.92B in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
AbbVie USD 4.34B 56M Jun/2025
Agios Pharmaceuticals USD -125.8M 20.45M Jun/2025
Alnylam Pharmaceuticals USD 381.78M 362.95M Sep/2025
Amgen USD 3.6B 147M Jun/2025
Astellas Pharma JPY 151.7B 11.36B Sep/2025
AstraZeneca USD 4.96B 127M Jun/2025
Biogen USD 1.01B 456.5M Jun/2025
BioMarin Pharmaceutical USD 295.45M 49.49M Jun/2025
Bristol-Myers Squibb USD 4.24B 967M Sep/2025
Eli Lilly USD 7.5B 3.34B Jun/2025
Gilead Sciences USD 4.03B 628M Sep/2025
GlaxoSmithKline GBP 3.18B 45M Jun/2025
Incyte USD 581.52M 358.87M Jun/2025
Ionis Pharmaceuticals USD -157.12M 307.36M Sep/2025
J&J USD 9.52B 389M Sep/2025
Kyowa Hakko Kirin JPY 32.28B 13.25B Sep/2025
Merck USD 8.39B 1.97B Sep/2025
Moderna USD -208M 552M Sep/2025
Neurocrine Biosciences USD 246.7M 93.8M Sep/2025
Novartis USD 5.88B 290M Sep/2025
Novartis USD 5.84B 235M Sep/2025
Pfizer USD 6.08B 351M Sep/2025
Regeneron Pharmaceuticals USD 1.92B 261.9M Sep/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 5.66B 3.77B Sep/2025
Sarepta Therapeutics USD 126.42M 416.82M Jun/2025
Teva Pharmaceutical Industries USD 1.64B 243M Dec/2025
Ultragenyx Pharmaceutical USD -91.34M 35.09M Jun/2025
United Therapeutics USD 436.8M 34.2M Jun/2025
Vertex Pharmaceuticals USD 1.44B 100.4M Sep/2025